Qing Kay Li MD, PhD

Dr. Li is an internationally recognized expert in the field of cytopathology and co-PI in Johns Hopkins Biomarker Discovery Center. She provides diagnostic service at Johns Hopkins, and conducts research in the field of novel biomarkers in lung and prostate cancers. Her research has been presented at many national/international meetings. Dr. Li also serves as editorial board members for several journals, committee member of the American Society of Cytopathology, and study sections of government agents and private organizations. She has more than 70 publications and book chapters. Dr. Li is also the editor of “Diagnostic Cytopathology Board Review and Self-Assessment.